Clinical Trials Browser

OTHER_GOV × Small Cell Lung Carcinoma × anlotinib × Clear all

NCT04660097 2022-04-12

Alotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer

Phase 2 Unknown

Small Cell Lung Carcinoma